Next Article in Journal
The Roles of Protein Tyrosine Phosphatases in Hepatocellular Carcinoma
Next Article in Special Issue
Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma
Previous Article in Journal
Aptamer Therapeutics in Cancer: Current and Future
Previous Article in Special Issue
Linking Extracellular Matrix Agrin to the Hippo Pathway in Liver Cancer and Beyond
Open AccessEditor’s ChoiceReview

Targeting the Hippo Pathway and Cancer through the TEAD Family of Transcription Factors

Department of Early Discovery Biochemistry, Genentech, Inc., South San Francisco, CA 94080, USA
*
Author to whom correspondence should be addressed.
Cancers 2018, 10(3), 81; https://doi.org/10.3390/cancers10030081
Received: 23 February 2018 / Revised: 15 March 2018 / Accepted: 16 March 2018 / Published: 20 March 2018
The Hippo pathway is a critical transcriptional signaling pathway that regulates cell growth, proliferation and organ development. The transcriptional enhanced associate domain (TEAD) protein family consists of four paralogous transcription factors that function to modulate gene expression in response to the Hippo signaling pathway. Transcriptional activation of these proteins occurs upon binding to the co-activator YAP/TAZ whose entry into the nucleus is regulated by Lats1/2 kinase. In recent years, it has become apparent that the dysregulation and/or overexpression of Hippo pathway effectors is implicated in a wide range of cancers, including prostate, gastric and liver cancer. A large body of work has been dedicated to understanding the therapeutic potential of modulating the phosphorylation and localization of YAP/TAZ. However, YAP/TAZ are considered to be natively unfolded and may be intractable as drug targets. Therefore, TEAD proteins present themselves as an excellent therapeutic target for intervention of the Hippo pathway. This review summarizes the functional role of TEAD proteins in cancer and assesses the therapeutic potential of antagonizing TEAD function in vivo. View Full-Text
Keywords: TEAD; Hippo; YAP; TAZ; cancer; transcription factor TEAD; Hippo; YAP; TAZ; cancer; transcription factor
Show Figures

Figure 1

MDPI and ACS Style

Holden, J.K.; Cunningham, C.N. Targeting the Hippo Pathway and Cancer through the TEAD Family of Transcription Factors. Cancers 2018, 10, 81. https://doi.org/10.3390/cancers10030081

AMA Style

Holden JK, Cunningham CN. Targeting the Hippo Pathway and Cancer through the TEAD Family of Transcription Factors. Cancers. 2018; 10(3):81. https://doi.org/10.3390/cancers10030081

Chicago/Turabian Style

Holden, Jeffrey K.; Cunningham, Christian N. 2018. "Targeting the Hippo Pathway and Cancer through the TEAD Family of Transcription Factors" Cancers 10, no. 3: 81. https://doi.org/10.3390/cancers10030081

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop